Calunod, Cherry Mae .
HRN: 11-18-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2025
METRONIDAZOLE 500MG (TAB)
12/10/2025
12/17/2025
PO
500mg
Q8
S/P Primary LTCS Wig Intracesarean IUD
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes